Figure 2.

The expression of activation markers in γδ T cells from the blood of healthy donors and COVID‐19 patients (A) The percentage of CD69 + γδ T cells; (B) the percentage of CD25 + γδ T cells; (C) the percentage of PD‐1 + γδ T cells

The expression of activation markers in γδ T cells from the blood of healthy donors and COVID‐19 patients (A) The percentage of CD69 + γδ T cells; (B) the percentage of CD25 + γδ T cells; (C) the percentage of PD‐1 + γδ T cells